港股異動 | 京東健康(6618.HK)三日累漲逾42% 中期收入同比增長55.4% 年度活躍用户數量達1.09億
格隆匯8月25日丨京東健康(6618.HK)漲12.66%,報82.75港元,三日累漲逾42%,總市值2637億港元。京東健康公佈2021年中期業績,收入約人民幣136.38億元,同比增長55.4%;毛利33.07億元,同比增長49.1%;期間虧損4.54億元,同比減少91.5%;期間非國際財務報吿準則盈利6.67億元,同比增長79.9%;公司所有者應占虧損約4.55億元,同比減少約91.51%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.